Related references
Note: Only part of the references are listed.Using technology to deliver cancer follow-up: a systematic review
Rebekah Dickinson et al.
BMC CANCER (2014)
A randomized controlled trial of the effectiveness of a pre-recruitment primer letter to increase participation in a study of colorectal screening and surveillance
Christine Paul et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Oxaliplatin induced-neuropathy in digestive tumors
Maria Sereno et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Nurses' experiences of using an interactive tailored patient assessment tool one year past implementation
Elin Borosund et al.
INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS (2014)
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients
Roser Velasco et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
Marta Seretny et al.
PAIN (2014)
Getting serious about test-retest reliability: a critique of retest research and some recommendations
Denise F. Polit
QUALITY OF LIFE RESEARCH (2014)
A descriptive study of persistent oxaliplatin-induced peripheral neuropathy in patients with colorectal cancer
Sina Vatandoust et al.
SUPPORTIVE CARE IN CANCER (2014)
A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration
A. J. M. Beijers et al.
SUPPORTIVE CARE IN CANCER (2014)
Supporting Cancer Patients in Illness Management: Usability Evaluation of a Mobile App
Jelena Mirkovic et al.
JMIR MHEALTH AND UHEALTH (2014)
Chemotherapy-Induced Peripheral Neurotoxicity: A Critical Analysis
Susanna B. Park et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy A Randomized Clinical Trial
Ellen M. Lavoie Smith et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors
Cindy Tofthagen et al.
SUPPORTIVE CARE IN CANCER (2013)
Long-Term Neurotoxicity Effects of Oxaliplatin Added to Fluorouracil and Leucovorin as Adjuvant Therapy for Colon Cancer: Results from National Surgical Adjuvant Breast and Bowel Project Trials C-07 and LTS-01
Kelley M. Kidwell et al.
CANCER (2012)
What sample sizes for reliability and validity studies in neurology?
Jeremy C. Hobart et al.
JOURNAL OF NEUROLOGY (2012)
Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients The introduction of a new measure
C. M. L. Driessen et al.
SUPPORTIVE CARE IN CANCER (2012)
Impact of oxaliplatin-induced neuropathy: a patient perspective
Barbara K. Bennett et al.
SUPPORTIVE CARE IN CANCER (2012)
Peripheral Neuropathy in Patients With Colorectal Cancer Receiving Oxaliplatin
Cindy Tofthagen et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2011)
Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: Secondary outcomes of a randomised controlled trial
Galina Velikova et al.
EUROPEAN JOURNAL OF CANCER (2010)
Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools
Guido Cavaletti et al.
EUROPEAN JOURNAL OF CANCER (2010)
The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes
Lidwine B. Mokkink et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2010)
Heated (37°C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?
Richard Cathomas et al.
SUPPORTIVE CARE IN CANCER (2010)
Optimal recall periods for patient-reported outcomes: challenges and potential solutions
Donald E. Stull et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Patients' perceptions and experiences of using a mobile phone-based advanced symptom management system (ASyMS©) to monitor and manage chemotherapy related toxicity
L. McCann et al.
EUROPEAN JOURNAL OF CANCER CARE (2009)
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cancer survivorship research: the challenge of recruiting adult long term cancer survivors from a cooperative clinical trials group
Patricia A. Ganz et al.
JOURNAL OF CANCER SURVIVORSHIP (2009)
Managing Toxicities Associated With Colorectal Cancer Chemotherapy and Targeted Therapy: A New Guide for Nurses
Nina N. Grenon et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2009)
Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
Sherry Wolf et al.
EUROPEAN JOURNAL OF CANCER (2008)
Nurse's perceptions and experiences of using of a mobile-phone-based Advanced Symptom Management System (ASyMS©) to monitor and manage chemotherapy-related toxicity
R. Maguire et al.
EUROPEAN JOURNAL OF ONCOLOGY NURSING (2008)
Background noise - The experience of chemotherapy-induced peripheral neuropathy
Marie A. Bakitas
NURSING RESEARCH (2007)
Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07
Stephanie R. Land et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Persistence of high-dose oxaliplatin-induced neuropathy at long-term follow-up
Alberto Pietrangeli et al.
EUROPEAN NEUROLOGY (2006)
Share Paper
